Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Net Income (2016 - 2025)

Historic Net Income for Pharma-Bio Serv (PBSV) over the last 15 years, with Q4 2025 value amounting to -$102.0.

  • Pharma-Bio Serv's Net Income fell 10063.31% to -$102.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$110021.0, marking a year-over-year increase of 8585.16%. This contributed to the annual value of -$100463.0 for FY2025, which is 8708.07% up from last year.
  • As of Q4 2025, Pharma-Bio Serv's Net Income stood at -$102.0, which was down 10063.31% from -$213808.0 recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Net Income ranged from a high of $2.3 million in Q3 2021 and a low of -$4.9 million during Q4 2021
  • Moreover, its 5-year median value for Net Income was $134366.0 (2022), whereas its average is -$33000.8.
  • Data for Pharma-Bio Serv's Net Income shows a peak YoY increase of 22872.01% (in 2021) and a maximum YoY decrease of 347565.8% (in 2021) over the last 5 years.
  • Pharma-Bio Serv's Net Income (Quarter) stood at -$4.9 million in 2021, then soared by 103.56% to $173379.0 in 2022, then tumbled by 127.19% to -$47148.0 in 2023, then soared by 134.17% to $16111.0 in 2024, then tumbled by 100.63% to -$102.0 in 2025.
  • Its last three reported values are -$102.0 in Q4 2025, -$213808.0 for Q3 2025, and $95353.0 during Q2 2025.